IRONWOOD PHARMACEUTICALS INC (IRWD) › Operating Cash FlowIRONWOOD PHARMACEUTICALS INC (IRWD) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: -$3.44M2010: -$67.90M2011: -$75.24M2012: -$69.63M2013: -$273.36M2014: -$155.57M2015: -$106.93M2016: -$25.93M2017: -$100.75M2018: -$70.88M2019: $10.72M2020: $168.84M2021: $261.89M2022: $273.76M2023: $183.43M2024: $103.55M2025: $127.04M$127.04M2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$127.04M+22.7%2024$103.55M-43.5%2023$183.43M-33.0%2022$273.76M+4.5%2021$261.89M+55.1%2020$168.84M+1474.2%2019$10.72M+115.1%2018-$70.88M+29.6%2017-$100.75M-288.5%2016-$25.93M+75.7%2015-$106.93M+31.3%2014-$155.57M+43.1%2013-$273.36M-292.6%2012-$69.63M+7.4%2011-$75.24M-10.8%2010-$67.90M-1870.9%2009-$3.44M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share